Team

Mr. Basso brings more than 30 years of experience of financial leadership, primarily in the pharmaceutical industry. Prior to joining Innoviva, Mr. Basso served as the Chief Financial Officer and Chief Operating Officer at Cybrexa Therapeutics and has held a variety of financial leadership positions at Inozyme Pharma, Alexion Pharmaceuticals and Pfizer. He received a BS in business from Providence College and an MBA from Boston College.

Dr. Altarac is an infectious diseases physician and pharmaceutical executive with more than 20-years’ experience leading clinical and regulatory functions. He previously served as the Chief Medical Officer of Entasis Therapeutics and held leadership positions at Shire Pharmaceuticals, NeoStem, Inc., and Merck & Co. in therapeutic areas including infectious diseases, oncology, ophthalmology, inflammation, and rare diseases. Dr. Altarac holds an M.D. degree from New York Medical College, a Master of Public Administration (M.P.A.) degree from New York University, and a B.A. in Chemistry from the State University of New York at Binghamton, NY.

Ms. Drake is a highly accomplished life science professional with over thirty years of extensive U.S. and international experience managing commercial portfolios. Her strong leadership background encompasses commercial strategy, marketing, market access, sales and operations. Prior to joining Innoviva Specialty Therapeutics, Ms. Drake served as the SVP and Chief Commercial Officer at Trevena, Inc. During her tenure at Merck & Co. Inc., she successfully led commercial organizations across diverse global markets and product portfolios, which included antiviral, oncology, antifungal, and antibiotic products and multiple global business units spanning North and South America and the Nordics. Ms. Drake holds a Bachelor of Science from Wichita State University and attended the Harvard Business School Emerging Leaders Program and Executive Program in Leadership and Strategy.

Pavel brings deep financial and strategic expertise from experiences at Sarissa Capital Management, Credit Suisse’s healthcare investment banking, and biopharmaceutical consulting at McKinsey & Company and BCG. He holds a BA from Harvard and an MBA from Columbia University.

Joining Innoviva in 2014, Marianne previously served as Corporate Controller for three tech companies. A member of the AICPA and the CalCPA, she also served on the CalCPA Peninsula Silicon Valley Chapter board. Marianne holds a BS in Business Administration from San Francisco State University.

Marcie is a seasoned executive who brings more than 25 years of human resources leadership experience, primarily in the life sciences industry. Prior to joining Innoviva, Marcie served as the Chief People Officer for Beta Bionics and has held a variety of HR leadership positions at MorphoSys, Boston Heart Diagnostics, HeartWare and Genzyme. Her most recent roles have been focused on rapidly growing and scaling life science companies while building a people-centric HR platform to support key business strategies. Marcie is passionate about the important and meaningful work we do every day to serve patients, support our employees and live our values. Marcie holds a BS in business and economics from Washington State University.